Trefoil Peptides in Lung Diseases
Sponsor
Bispebjerg Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT00839735
Collaborator
(none)
60
1
14.9
4
Study Details
Study Description
Brief Summary
The study focuses on trefoil family factor (TFF) peptides in sputum in lung diseases. The investigators hypothesize that TFF peptides are upregulated in lung diseases characterized by mucus hypersecretion.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Study Design
Study Type:
Observational
Actual Enrollment
:
60 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Trefoil Peptides in Lung Diseases
Study Start Date
:
Feb 1, 2009
Actual Primary Completion Date
:
May 1, 2010
Actual Study Completion Date
:
May 1, 2010
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
COPD Chronic obstructive pulmonary disease |
|
Asthma
|
|
Healthy controls
|
Outcome Measures
Primary Outcome Measures
- TFF in sputum [Monthly]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
-
Age 18 years or older
-
Informed consent
Exclusion Criteria:
- Upper and lower airway infection 2 weeks prior to visit 1
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Respiratory and Allergy Research Unit, Department of Respiratory Medicine L, Bispebjerg Hospital | Copenhagen | Denmark | 2400 |
Sponsors and Collaborators
- Bispebjerg Hospital
Investigators
- Principal Investigator: Thomas K Lund, MD PhD, Respiratory and Allergy Research Unit
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
Thomas Lund,
MD,
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT00839735
Other Study ID Numbers:
- H-B-2008-120
First Posted:
Feb 9, 2009
Last Update Posted:
Feb 17, 2021
Last Verified:
Feb 1, 2021
Keywords provided by Thomas Lund,
MD,
Bispebjerg Hospital
Additional relevant MeSH terms: